arrow
M

M Bergmann

south london & maudsley nhs trust
H指数:11
被引数:800

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial

每周一次司美格鲁肽与安慰剂在酒精使用障碍合并肥胖患者中的比较:一项随机、双盲、安慰剂对照试验

2026-04-300
OAAI
Phosphatidylethanol and self-reported alcohol intake to subclassify in individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study

磷脂乙醇和自我报告的酒精摄入量用于对脂肪性肝病风险个体的亚组分类:一项前瞻性队列研究数据的分析

2025-09-100
PRE
High Plasma 18β-Glycyrrhetinic Acid Levels Are Associated With More Intensive Antihypertensive Treatment, Resistant Hypertension and Apparent Mineralocorticoid Excess in Patients With Type 2 Diabetes

高血浆18β-甘草次酸水平与更密集的抗高血压治疗、难治性高血压以及明显盐皮质激素过多症在2型糖尿病患者中相关联。

2025-06-020
PRE
Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake

脂肪性肝病和过量饮酒患者的酒精摄入量量化

2025-01-011
OAAI
Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial
2022-10-1076
OAAI
Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: Prevalence and correlation between DPYD-genotype mutations and P-uracil concentrations
2022-06-010
OA